Abbott To Pay $385M To End FCA Claims Over Infant Formula
The U.S. Department of Justice on Monday said that Abbott Laboratories has agreed to pay nearly $385 million to end False Claims Act allegations over the manufacture of contaminated infant formula...To view the full article, register now.
Already a subscriber? Click here to view full article